Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dexter Kai Hao Thng

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|January 10, 2021
Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital AgeDexter Kai Hao Thng, Tan Boon Toh, Edward Kai-Hua Chow
Communications Medicine|January 4, 2026
Artificial intelligence for breast cancer managementBryan Nicholas Chua, Dexter Kai Hao Thng, Tan Boon Toh, et al.
Experimental Hematology & Oncology|April 13, 2024
Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive reviewYating Shen, Dexter Kai Hao Thng, Andrea Li Ann Wong, et al.
Hepatic Oncology|April 11, 2020
JAK/STAT signaling in hepatocellular carcinomaJustin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
Oncogenesis|January 19, 2026
The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1Dexter Kai Hao Thng, Lissa Hooi, Wai Khang Yong, et al.
Nanoscale|September 20, 2021
Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D modelsJingru Xu, Mengjie Gu, Lissa Hooi, et al.
Experimental & Molecular Medicine|January 7, 2026
The functional imperative in high-grade gliomaLaura Shih Hui Goh, Dexter Kai Hao Thng, Yvonne Li En Ang, et al.
ACS Sensors|May 2, 2023
NanoBeacon.AI: AI-Enhanced Nanodiamond Biosensor for Automated Sensitivity Prediction to Oxidative Phosphorylation InhibitorsJingru Xu, Mengjia Zheng, Dexter Kai Hao Thng, et al.
Bioengineering & Translational Medicine|January 23, 2023
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinomaDexter Kai Hao Thng, Tan Boon Toh, Paolo Pigini, et al.
Hepatology Communications|September 14, 2020
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma ProgressionYong Chun Chong, Tan Boon Toh, Zhiling Chan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|January 10, 2021
Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital AgeDexter Kai Hao Thng, Tan Boon Toh, Edward Kai-Hua Chow
Communications Medicine|January 4, 2026
Artificial intelligence for breast cancer managementBryan Nicholas Chua, Dexter Kai Hao Thng, Tan Boon Toh, et al.
Experimental Hematology & Oncology|April 13, 2024
Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive reviewYating Shen, Dexter Kai Hao Thng, Andrea Li Ann Wong, et al.
Hepatic Oncology|April 11, 2020
JAK/STAT signaling in hepatocellular carcinomaJustin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
Oncogenesis|January 19, 2026
The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1Dexter Kai Hao Thng, Lissa Hooi, Wai Khang Yong, et al.
Nanoscale|September 20, 2021
Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D modelsJingru Xu, Mengjie Gu, Lissa Hooi, et al.
Experimental & Molecular Medicine|January 7, 2026
The functional imperative in high-grade gliomaLaura Shih Hui Goh, Dexter Kai Hao Thng, Yvonne Li En Ang, et al.
ACS Sensors|May 2, 2023
NanoBeacon.AI: AI-Enhanced Nanodiamond Biosensor for Automated Sensitivity Prediction to Oxidative Phosphorylation InhibitorsJingru Xu, Mengjia Zheng, Dexter Kai Hao Thng, et al.
Bioengineering & Translational Medicine|January 23, 2023
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinomaDexter Kai Hao Thng, Tan Boon Toh, Paolo Pigini, et al.
Hepatology Communications|September 14, 2020
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma ProgressionYong Chun Chong, Tan Boon Toh, Zhiling Chan, et al.
Pageof 2